Allen Lutz
Stock Analyst at Bank of America Securities
(4.71)
# 724
Out of 4,399 analysts
558
Total ratings
64.9%
Success rate
11.2%
Average return
Main Sectors:
Stocks Rated by Allen Lutz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintained: Buy | $900 | $790.44 | +13.86% | 33 | Jun 8, 2026 | |
| DOCS Doximity | Maintained: Buy | $47 → $38 | $20.24 | +87.75% | 41 | Jun 5, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 | $25.89 | +19.74% | 22 | Jun 2, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $125 | $89.72 | +39.32% | 55 | May 29, 2026 | |
| TDOC Teladoc Health | Maintained: Buy | $9 | $7.03 | +28.02% | 76 | May 28, 2026 | |
| HIMS Hims & Hers Health | Maintained: Hold | $28 → $25 | $27.78 | -10.01% | 70 | May 28, 2026 | |
| COR Cencora | Maintained: Hold | $280 | $281.24 | -0.44% | 20 | May 27, 2026 | |
| HSIC Henry Schein | Maintained: Buy | n/a | $78.85 | - | 22 | May 14, 2026 | |
| NVST Envista Holdings | Maintained: Buy | $34 | $24.06 | +41.31% | 21 | May 14, 2026 | |
| CAH Cardinal Health | Maintained: Buy | $240 | $216.30 | +10.96% | 19 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $38.18 | +83.34% | 30 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $100 | $98.02 | +2.02% | 30 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $41.97 | +0.07% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $10.04 | +69.32% | 22 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.80 | - | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3.5 | $0.8315 | +320.93% | 12 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.25 | $2.74 | -17.88% | 16 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.6 → $1.9 | $2.56 | -25.78% | 30 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.42 | n/a | 11 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $4.59 | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $41 | $0.0001 | n/a | 2 | Aug 10, 2022 |
McKesson
Jun 8, 2026
Maintained: Buy
Price Target: $900
Current: $790.44
Upside: +13.86%
Doximity
Jun 5, 2026
Maintained: Buy
Price Target: $47 → $38
Current: $20.24
Upside: +87.75%
Progyny
Jun 2, 2026
Reiterated: Buy
Price Target: $31
Current: $25.89
Upside: +19.74%
HealthEquity
May 29, 2026
Reiterated: Buy
Price Target: $125
Current: $89.72
Upside: +39.32%
Teladoc Health
May 28, 2026
Maintained: Buy
Price Target: $9
Current: $7.03
Upside: +28.02%
Hims & Hers Health
May 28, 2026
Maintained: Hold
Price Target: $28 → $25
Current: $27.78
Upside: -10.01%
Cencora
May 27, 2026
Maintained: Hold
Price Target: $280
Current: $281.24
Upside: -0.44%
Henry Schein
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $78.85
Upside: -
Envista Holdings
May 14, 2026
Maintained: Buy
Price Target: $34
Current: $24.06
Upside: +41.31%
Cardinal Health
May 13, 2026
Maintained: Buy
Price Target: $240
Current: $216.30
Upside: +10.96%
May 12, 2026
Reiterated: Buy
Price Target: $70
Current: $38.18
Upside: +83.34%
May 7, 2026
Maintained: Buy
Price Target: $95 → $100
Current: $98.02
Upside: +2.02%
May 7, 2026
Reiterated: Buy
Price Target: $42
Current: $41.97
Upside: +0.07%
May 6, 2026
Reiterated: Buy
Price Target: $17
Current: $10.04
Upside: +69.32%
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $18.80
Upside: -
Apr 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $0.8315
Upside: +320.93%
Mar 31, 2026
Reiterated: Sell
Price Target: $2.25
Current: $2.74
Upside: -17.88%
Feb 26, 2026
Reiterated: Sell
Price Target: $2.6 → $1.9
Current: $2.56
Upside: -25.78%
Aug 5, 2024
Rated: Hold
Price Target: n/a
Current: $8.42
Upside: n/a
Jun 20, 2023
Maintained: Hold
Price Target: $12
Current: $4.59
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: $50 → $41
Current: $0.0001
Upside: n/a